Private Equity Archives - Gilde Healthcare

Menu
Menu
Home

Neuigkeiten & Einblicke
Private Equity

Gilde Healthcare company Noema Pharma raises CHF 103 million ($112 million)

Gilde Healthcare, a leading specialized healthcare investor, today announced that its portfolio company Noema Pharma, has raised an oversubscribed CHF 103 million ($112 million) Series B financing round from new and existing investors. Noema Pharma is a clinical-stage biopharma company targeting debilitating central nervous system (CNS) disorders. The financing round was completed by an international syndicate led by new investors...
7. März 2023

Gilde Healthcare company Synexa Life Sciences celebrates its 20th anniversary

test Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights Synexa Life Sciences, a specialist biomarker and bioanalysis services provider, celebrates its 20th anniversary on March the 3rd 2023. Since its inception in 2003, Synexa Life Sciences has become a trusted partner to pharmaceutical, biotech, academic and non-profit organizations all over the […]

Gilde Healthcare sells its stake in Zetacom to facilitate a merger with Detron

test The Private Equity fund of Gilde Healthcare, the leading European specialist healthcare investor, has reached an agreement to sell its majority stake in Zetacom to Avedon Capital, a leading mid-market private equity firm in the Benelux and DACH-region. Avedon will merge the company with Detron, an independent IT service provider. The transaction is still subject […]

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment...

Gilde Healthcare company Zetacom acquires communication specialist Ooperon

Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.

Gilde Healthcare investiert in deutschen Präzisionshersteller chirurgischer Instrumente – Chr. Diener

Traditionsunternehmen mit 122-jähriger Unternehmensgeschichte und führender Auftrags-hersteller hochkomplexer, chirurgischer Instrumente stellt Weichen für die Zukunft durch Partnerschaft mit Gilde Healthcare.

Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.

Gilde Healthcare legt vierten Private Equity Fonds mit einem Volumen von mehr als 500 Millionen Euro für Investitionen in Nordwesteuropa auf

Der überzeichnete Fonds will in profitable kleine und mittlere Unternehmen im Gesundheitswesen in Nordwesteuropa investieren. Zusammen mit dem Venture&Growth Fonds konnten innerhalb von 2 Jahren 933 Millionen Euro aufgenommen werden. Gilde Healthcare gab heute bekannt, dass der Gilde Healthcare Private Equity IV (GHPE IV) Fonds mit einem...

Gilde Healthcare Private Equity übernimmt den medizintechnischen Auftragshersteller EUROPIN

Durch den Zusammenschluss mit Acti-Med, einem Portfoliounternehmen von Gilde Healthcare, entsteht einer der größten Auftragshersteller von medizinischen Kanülen und Kanülensystemen in Europa. Der Private Equity Fonds von Gilde Healthcare, ein auf das Gesundheitswesen spezialisierter Investor, hat EUROPIN übernommen, einen international führenden Entwickler und Auftragshersteller von Pen-Kanülen und...
Loading...
These were all messages
56fe76ef55